Detalhe da pesquisa
1.
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma.
N Engl J Med
; 384(22): 2102-2114, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34077643
2.
Treatment of muscle-invasive urothelial cancer with nivolumab (CheckMate 274 study): a plain language summary.
Future Oncol
; 19(6): 413-426, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36919916
3.
Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumors.
Invest New Drugs
; 39(1): 142-151, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32556884
4.
Bempegaldesleukin plus nivolumab in untreated, unresectable or metastatic melanoma: Phase III PIVOT IO 001 study design.
Future Oncol
; 16(28): 2165-2175, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32723187
5.
Immune checkpoint inhibitor-induced sarcoidosis-like granulomas.
Int J Clin Oncol
; 24(10): 1171-1181, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31321613
6.
Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 16(5): 536-563, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29752328
7.
A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607).
Cancer
; 123(14): 2688-2697, 2017 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28334439
8.
Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 14(6): 758-86, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27283169
9.
Update on primary mucosal melanoma.
J Am Acad Dermatol
; 71(2): 366-75, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24815565
10.
What is the role of chemotherapy in the treatment of melanoma?
Curr Treat Options Oncol
; 15(2): 321-35, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24599525
11.
Current systemic therapies for melanoma.
Dermatol Surg
; 40(9): 948-63, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25072125
12.
CpG methylation as a tool to characterize cell-free Kaposi sarcoma herpesvirus DNA.
J Infect Dis
; 205(7): 1095-9, 2012 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22357696
13.
Eosinophilic Infiltrates in Vemurafenib-Associated Verrucous Keratoses.
Am J Dermatopathol
; 38(10): 766-8, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27533075
14.
Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis.
J Immunother Cancer
; 9(5)2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33963015
15.
Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial.
J Transl Med
; 8: 108, 2010 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21044351
16.
Evolving impact of long-term survival results on metastatic melanoma treatment.
J Immunother Cancer
; 8(2)2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33037115
17.
Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609.
J Clin Oncol
; 38(6): 567-575, 2020 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31880964
18.
Rational design of anti-GITR-based combination immunotherapy.
Nat Med
; 25(5): 759-766, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31036879
19.
Acneiform eruptions associated with vemurafenib.
J Am Acad Dermatol
; 68(3): e97-9, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23394928
20.
Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer.
Clin Cancer Res
; 13(7): 2100-8, 2007 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17404092